AstraZeneca Plc - Company Profile
Powered by 
All the data and insights you need on AstraZeneca Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date AstraZeneca Plc Strategy Report
- Understand AstraZeneca Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreBusiness Description
AstraZeneca Plc (AstraZeneca) discovers, develops and commercializes innovative prescription medicines, essentially for the treatment of cancer, respiratory, cardiovascular and renal and metabolic diseases therapy areas. It is also active in the areas of autoimmunity, neuroscience and infection.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
AstraZeneca's key R&D capabilities include small molecules, oligonucleotides and other emerging drug platforms. It also includes biologic medicines, comprising immunotherapies and novel delivery devices. It is working on combining artificial and human intelligence to find unexplored patterns and draw better, faster conclusions. Other R&D focus areas include oncology, single-cell sequencing, cell therapy research and AI-driven genomic technology. It has R&D facilities in Cambridge and Macclesfield, the UK; Gothenburg, Sweden; Gaithersburg (Maryland), Boston (Massachusetts) and California, the US; Shanghai, China; and Osaka, Japan. As of December 31, 2022, AstraZeneca had 179 projects in its pipeline and 15 new molecular entities (NMEs) in its late-stage pipeline. AstraZeneca collaborates with academia, industry, scientific organizations, governments and patient groups to access leading science to stimulate innovation and accelerate the delivery of novel medicines. It also collaborates with scientists at leading institutions to understand disease, discover probable new drugs and accelerate drug development. As of December 31, 2022, it had over 1,000 collaborations worldwide. In FY2022, the company spent US$9,612 million on R&D activities. It owns numerous domestic and foreign patents covering biopharmaceuticals and their uses, product manufacturing processes and pharmaceutical formulations. It obtained patent protection in more than 90 countries worldwide.
Product Categories
- Cardiovascular, Renal and Metabolism
- COVID-19
- Oncology
- Others
- Rare Diseases
- Respiratory & Immunology
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Other Break-up
Overview
Comprises development, commercialization and collaboration revenue such as milestone receipts and royalties.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Discovers, develops and commercializes prescription pharmaceuticals to treat cancer, cardiovascular, renal and metabolic disease, respiratory diseases and other diseases. -Principal brands include Faslodex (breast cancer); Tagrisso (metastatic EGFR T790M mutation-positive NSCLC); Iressa (advanced NSCLC); Lynparza (recurrent ovarian cancer and gBRCA HER2-negative metastatic breast cancer); Crestor (dyslipidaemia and hypercholesterolaemia); Brilinta (post myocardial infarction and acute coronary syndromes); Farxiga (Type 2 diabetes); Pulmicort (asthma); Symbicort (asthma and COPD); Nexium (acid-related diseases); and Synagis (RSV infection in pediatric patients). -Considers product innovation, acquisitions and partnerships as critical factors for growth.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer